Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03528733
Other study ID # KAIGRH1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 22, 2018
Est. completion date June 1, 2021

Study information

Verified date January 2020
Source KA Imaging Inc.
Contact Tracy Nelson
Phone (519) 749-4370
Email Tracy.Nelson@grhosp.on.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A single-centre, industry sponsored, pilot study to assess the feasibility of Single Exposure Dual Energy Subtraction with a Multi-Energy digital radiography detector as an imaging platform for lung lesion detection.


Description:

A feasibility study is proposed to investigate the imaging characteristics captured by a Single Exposure Dual-Energy Subtraction digital radiography with KA Imaging's Multi-energy detector.

The acquisition of Dual-Energy Subtraction radiography will consist of using the Multi-Energy detector integrated into the X-ray system in Grand River Hospital. Patient will receive a Multi-Energy Chest radiography exam on the same day as their routine chest CT exam. Each Multi-Energy radiography exam will consist of one Chest PA image and one Chest LAT image. Duration of each procedure is 60 minutes. The Multi-Energy Detector will generate a General Radiography Image and Dual-Energy Subtracted Images.

Visualization of lung lesions by Multi-Energy detector will be compared to corresponding CT exam and general radiography results. Imaging data will be evaluated qualitatively by radiologists on data collection form to describe the findings on the images. Further comparison between general radiography, Dual-Energy Subtraction radiography and CT will be analyzed to determine the differences of imaging characteristics such as description of image quality and visibility of relevant anatomical structures and anomalies.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 1, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18 years and older.

- Patients with previously diagnosed carcinoma with lung metastases, or patients with previously detected lung nodule

- Subject is able to provide informed consent

- Study participant is scheduled to have a chest CT exam as part of their routine care.

- Study participant is able to stand and be still during the exams.

Exclusion Criteria:

- Not able or willing to provide Informed Consent, or consent is withdrawn.

- Study participant is pregnant

- Study participant is unable to perform standard radiography exam and CT exam

Study Design


Intervention

Device:
Multi-Energy Digital Radiography Detector System
A Multi-energy digital flat panel detector for Single Exposure Dual-Energy Subtraction radiography is developed to capture x-ray images with improved tissue differentiation. Tissue-selective images can be produced at various tissue levels such as bone and soft tissue to visualize obscured anomalies that are not apparent to General Radiography.

Locations

Country Name City State
Canada Grand River Hospital Kitchener Ontario

Sponsors (2)

Lead Sponsor Collaborator
KA Imaging Inc. Grand River Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Multi-Energy images will be compared to baseline Chest CT images for visualizing lung lesions. Multi-Energy images will be compared to baseline Chest CT images for visualizing lung lesions, as determined. Expert readers will qualitatively evaluate the imaging differences (e.g. motion artifacts, technical defects, ease of anomalies identification, etc) with an evaluation form with a questionnaire grading system (i.e. 1 (severe defect), 2 (moderate defect) to 5 (no defect)). 3 months
Secondary Multi-Energy images will be compared to standard radiography images for visualizing lung lesions. Multi-Energy images will be compared to standard radiography images for visualizing lung lesions, as determined. Expert readers will qualitatively evaluate the imaging differences (e.g. motion artifacts, technical defects, ease of anomalies identification, etc) with an evaluation form with a questionnaire grading system (i.e. 1 (severe defect), 2 (moderate defect) to 5 (no defect)). 3 months
See also
  Status Clinical Trial Phase
Terminated NCT05066776 - Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
Completed NCT01958931 - Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer N/A
Recruiting NCT02693496 - Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
Completed NCT01566682 - A Multi-Center Trial of the ProLung Test™
Terminated NCT02983903 - Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions N/A
Terminated NCT02050724 - ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT Phase 2
Not yet recruiting NCT04615156 - 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography Phase 3
Recruiting NCT02726633 - Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer N/A
Active, not recruiting NCT02623712 - The Watch the Spot Trial N/A
Recruiting NCT03568799 - 4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules N/A
Not yet recruiting NCT02817048 - Tubeless VATS for Peripheral Lung Nodule N/A
Recruiting NCT01149187 - Usefulness of Interferon-gamma Release Assay in Diagnosing Pulmonary Nodules N/A
Completed NCT00925210 - Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach Phase 2
Completed NCT02448225 - 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Phase 2
Active, not recruiting NCT05171491 - LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
Terminated NCT04140474 - Evaluation of the Archimedes ™ System for Transparenchymatous Access to Pulmonary Nodules. N/A
Withdrawn NCT05804435 - iNod™ Ultrasound-Guided Needle Biopsy System Study N/A
Not yet recruiting NCT02653859 - Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules N/A
Completed NCT02832284 - iNod System Human Feasibility Assessment N/A
Recruiting NCT02773992 - Clinical Study of Three Plus Two Type Early Diagnosis of Pulmonary Nodules in Medical Internet of Things N/A